FDA Investigator David Perkins

David Perkins has inspections in 4 countries as of 06 Oct 2023. David Perkins has collaborated with a combinined 3961 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
47
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, United Kingdom of Great Britain and Northern Ireland, Switzerland, Norway
Co-Investigator(s):
Ademola O Daramola, Aditi S Thakur, Alan M Barker, Alan M Roberts, Alberto A Viciedo, Alecia L Marson, Alice S Tsao, Alicia M Mozzachio, Amanda S Zorn, Ana E Morales, Ana L Kewes, Anastasia M Shields, Andrew A Leboeuf, Andrew J Barrowcliff, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Anthony R Petriella, Anthony R Ronga, Arsen Karapetyan, Ashar P Parikh, Ashley L Reiber, Azza Talaat, Barbara M Frazier, Barry Cherney, PhD, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Bruce H Mccullough, Bruce Mccullough, Bryan L Mcguckin, Burnell M Henry, Carl A Huffman, III, Carlyn L Ray, Carmen M Faraianu, Carol L Rehkopf, Caroline H Le, Carrie Ann Plucinski, CDR Sean T Creighton, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charles L Zhou, Cheryl A Fuhs, Cheryl M Monroe, Christian D Lynch (CDL), Christina A Miller, Christina V Santos, Christopher B Harding, Christopher D Leach, Claire M Minden, Constantin Y Philopoulos, Corrine M Carter, Daniel J Brown, Dariusz Galezowski, Darrell E Luedtke, Darren S Morgan, David J Gasparovich, Deborah M Trout, Debra I Love, Denise L Burosh, Denise M Digiulio, Don H Bark, PhD, Dr. Andrew Shroke, Dr. Gang Wang, PhD, Eboni S Funderburk, Eliezar Ramos, Elizabeth L Philpy, Emily J Orban, Eric M Mueller, PharmD, Eric S Pittman, Gale E Ryan, Gene D Arcy, Geneve M Maxwell, Gregory Price, Gregory R Dill, Howard Sklamberg, Humera Khan, Humera T Khan, Jacob G Luts, Jacob G Lutz, Jacqueline Mdiaz Albertini, James W Plucinski, Janae D Price, Jason F Chancey, Jeanne J Chiu, Jeanne M Morris, Jeffrey D Meng, Jennifer A D'angelo, Jennifer A Kemp, Jennifer L Schmidt, Jesse A Vazquez, Joan A Loreng, Jocelyn C Turner, John M Seale, Jose Acruz Gonzalez, Joseph A Morkunas, Joseph A Piechocki, Joshua M Adams, Joshua P Wireman, Justin A Boyd, Karen Emasley Joseph, Kellia N Hicks, Kerry L Edwards, III, Kristen D Jarell, Kristen E Szenderski, Kshitij A Patkar, Kyran R Gibson, Lana K Waselewski, Larry F Hallberg, Latoya A Griffith, Laura Fontan, MS, Laurel A Beer, Laurie A Haxel, LCDR Debra Emerson, LCDR Randall L Morris, Lequita M Mayhew, Leslie A Paul, Liliya V Bubiy, Linda F Murphy, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Lorelei S Jarrell, Maksim A Levenchuk, Margaret Torres Vazquez, Mark E Frank, Mark G Peterson, Mark I Kaspar, Marlene G Swider, Martha Sullivan Mynck, Martha Sullivan Myrick, Martin K Yan, PhD, Michael D Robinson, Michael J Nerz, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele Perry Williams, Micmarie Ramos, Mihaly S Ligmond, Mra Mcculloughj, Natasha R Johnson, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Niketa Patel, Norman K Starks, Norman L Brown, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick C Klotzbuecher, Patsy J Domingo, Paul M Kawamoto, Paula A Trost, Paula P Demichael, Phung Thien Nguyen, Prabhu P Raju, Rabin N Ghoshal, Rachel T Evans, Rafael Padilla, Ralph A Erickson, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Regina T Brown, Richard H Penta, Richard Heath Coats, Richard T Riggie, Robert D Tollefsen, Roberta W Cunningham, Rona Leblanc, PhD, Rose M Ashley, Rosemary A Sexton, Ross J Grigsby, Russ R Rivy, Russell K Riley, Samina S Khan, Samuel A Hamblin, Samuel W Labinjo, Sandra A Boyd, Sandra A Hughes, Santos E Camara, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sean R Bryd, Shafiq S Ahadi, Simone E Pitts, Stacie A Woods, State Agency, Stephen C Mahoney, Stephen D Brown, Stephen D Eich, Sullan, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Tamara Brey, That Q Dang, Thomas J Arista, Todd M Stankewicz, Tonia F Bernard, Tracey Asinjen Wiersma, Unnee Ranjan, Vaishali J Patel, Vioela J Caze, William D Tingley, William G Nelson, William R Weissinger, Yonggang Wang, PhD, Yvonne E Lozano, Yvonne Lozano, Zachary A Bogorad, Zerita White, Zhongren Wu

David Perkins's Documents

Publish Date Document Type Title
December, 2002 FDA 483 American Blending & Filling Company, Inc. - Form 483, 2002-12-03
July, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-07-20
April, 2001 FDA 483 Baxter Healthcare Corporation - Form 483, 2001-04-13
June, 2002 FDA 483 Penn Pharmaceutical Services Limited - Form 483, 2002-06-28
April, 2002 EIR Baxter Healthcare Corporation - EIR, 2002-02-11
August, 2002 EIR AndersonBrecon, Inc. d.b.a. PCI of Illinois - EIR, 2002-08-05
February, 2001 FDA 483 Toxicology Research Lab/UIC - Form 483, 2001-02-07
August, 2001 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2001-09-07
May, 2001 FDA 483 CSL Behring L.L.C. - Form 483, 2001-05-24
March, 2002 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2002-09-03
May, 2000 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2000-05-04
August, 2001 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2001-08-16
May, 2003 FDA 483 A-S Medication Solutions LLC - Form 483, 2003-05-02
March, 2001 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2001-03-23
March, 2002 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2002-03-08
September, 2002 FDA 483 Response AbbVie Inc. - Form 483R, 2002-10-04
June, 2002 EIR CSL Behring L.L.C. - EIR, 2002-06-06
June, 2002 FDA 483 CSL Behring L.L.C. - Form 483, 2002-06-06
May, 2001 EIR CSL Behring L.L.C. - EIR, 2001-05-24
April, 2002 EIR Steris Isomedix Services - EIR, 2002-04-25
August, 2002 EIR ANDERSONBRECON INC. - EIR, 2002-08-07
January, 2001 EIR SGS North America Inc. - EIR, 2001-01-05
December, 2002 EIR American Blending & Filling Company, Inc. - EIR, 2002-12-03
March, 2003 EIR AbbVie Inc. - EIR, 2003-03-28
September, 2002 FDA 483 AbbVie Inc. - Form 483, 2002-09-20
May, 2000 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2000-05-04
June, 2000 EIR AbbVie Inc. - EIR, 2000-06-19
March, 2003 FDA 483 Response AbbVie Inc. - Form 483R, 2003-04-17
April, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-03-01
October, 2000 EIR Precision Dose Inc. - EIR, 2000-10-05
March, 2003 FDA 483 AbbVie Inc. - Form 483, 2003-03-28
March, 2002 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2002-03-08
May, 2000 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2000-05-22
July, 2001 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2001-07-20
October, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-10-19
August, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-08-16
April, 2002 EIR Abbott Laboratories - EIR, 2002-04-03
January, 2001 FDA 483 Response SGS North America Inc. - Form 483R, 2001-01-24
May, 2003 EIR A-S Medication Solutions LLC - EIR, 2003-05-02
June, 2002 EIR PENN PHARMACEUTICAL SERVICES LIMITED - EIR, 2002-06-28
July, 2000 FDA 483 L. Perrigo Company - Form 483, 2000-07-14
April, 2001 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2001-04-23
April, 2002 FDA 483 Abbott Laboratories - Form 483, 2002-04-03
April, 2002 FDA 483 Baxter Healthcare Corporation - Form 483, 2002-02-11
February, 2001 FDA 483 Response Toxicology Research Lab/UIC - Form 483R, 2001-03-12
February, 2001 EIR Toxicology Research Lab/UIC - EIR, 2001-02-07
April, 2001 EIR Baxter Healthcare Corporation - EIR, 2001-04-13
March, 2001 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2001-03-01
August, 2002 EIR ANDERSONBRECON INC. - EIR, 2002-08-02
April, 2002 FDA 483 Response Abbott Laboratories - Form 483R, 2002-04-18
June, 2002 FDA 483 Response CSL Behring L.L.C. - Form 483R, 2002-08-21
January, 2001 FDA 483 SGS North America Inc. - Form 483, 2001-01-05
August, 2002 EIR AndersonBrecon Inc. - EIR, 2002-08-06
June, 2002 FDA 483 Response PENN PHARMACEUTICAL SERVICES LIMITED - Form 483R, 2002-07-11
March, 2001 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2001-03-01
April, 2002 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2002-04-12
September, 2002 EIR AbbVie Inc. - EIR, 2002-09-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more